Sender Co & Partners »

Celldex Therapeutics Inc New call shares owned by Sender Co & Partners

Quarter-by-quarter ownership of Celldex Therapeutics Inc New call shares owned by Sender Co & Partners from 13F filings

Historical chart of Sender Co & Partners investment in Celldex Therapeutics Inc New call

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics Inc New call held by Sender Co & Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics Inc New call by Sender Co & Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $425k 13k 31.72
2025-06-30 $265k 13k 20.35

More positions owned by Sender Co & Partners

Kenvue (KVUE)
Boeing Company (BA)
Eli Lilly & Co Call Call Option
Kimberly-Clark Corporation (KMB)
Eli Lilly & Co. (LLY)
Select Sector Spdr Tr State Street Hea (XLV)
Aurora Innovation Class A Com (AUR)
Nlight (LASR)
Apple (AAPL)
Roblox Corp Cl A (RBLX)
Core Scientific Call Call Option
Fair Isaac Corporation (FICO)
Lionsgate Studios Corp Call Call Option
Nextnav Common Stock (NN)
Honeywell International (HON)

View all positions for Sender Co & Partners

Top funds holding Celldex Therapeutics Inc New call

Sender Co & Partners
Group One Trading

View all funds holding Celldex Therapeutics Inc New call